0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Like Growth Factor 1 Receptor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-21Q7185
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Insulin Like Growth Factor 1 Receptor Market Insights Forecast to 2028
BUY CHAPTERS

Global Insulin Like Growth Factor 1 Receptor Market Research Report 2025

Code: QYRE-Auto-21Q7185
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insulin Like Growth Factor 1 Receptor Market

The global market for Insulin Like Growth Factor 1 Receptor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Insulin Like Growth Factor 1 Receptor include Astellas Pharma Inc., AstraZeneca Plc, Axelar AB, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab A/S, Immunomedics, Inc., Insmed Incorporated, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Like Growth Factor 1 Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Like Growth Factor 1 Receptor.
The Insulin Like Growth Factor 1 Receptor market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Like Growth Factor 1 Receptor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Like Growth Factor 1 Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Like Growth Factor 1 Receptor Market Report

Report Metric Details
Report Name Insulin Like Growth Factor 1 Receptor Market
Segment by Type
  • BI-893923
  • CT-707
  • 1R-E1
  • ATL-1101
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma Inc., AstraZeneca Plc, Axelar AB, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab A/S, Immunomedics, Inc., Insmed Incorporated, Merck & Co., Inc., Merrimack Pharmaceuticals, Inc., Novartis AG, PharmAbcine, Inc., ProteoThera, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Insulin Like Growth Factor 1 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Insulin Like Growth Factor 1 Receptor Market report?

Ans: The main players in the Insulin Like Growth Factor 1 Receptor Market are Astellas Pharma Inc., AstraZeneca Plc, Axelar AB, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab A/S, Immunomedics, Inc., Insmed Incorporated, Merck & Co., Inc., Merrimack Pharmaceuticals, Inc., Novartis AG, PharmAbcine, Inc., ProteoThera, Inc.

What are the Application segmentation covered in the Insulin Like Growth Factor 1 Receptor Market report?

Ans: The Applications covered in the Insulin Like Growth Factor 1 Receptor Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Insulin Like Growth Factor 1 Receptor Market report?

Ans: The Types covered in the Insulin Like Growth Factor 1 Receptor Market report are BI-893923, CT-707, 1R-E1, ATL-1101, Others

Recommended Reports

Growth Factor Markets

Insulin & Analogs

Receptor Drugs

1 Insulin Like Growth Factor 1 Receptor Market Overview
1.1 Product Definition
1.2 Insulin Like Growth Factor 1 Receptor by Type
1.2.1 Global Insulin Like Growth Factor 1 Receptor Market Value Comparison by Type (2024 VS 2031)
1.2.2 BI-893923
1.2.3 CT-707
1.2.4 1R-E1
1.2.5 ATL-1101
1.2.6 Others
1.3 Insulin Like Growth Factor 1 Receptor by Application
1.3.1 Global Insulin Like Growth Factor 1 Receptor Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Insulin Like Growth Factor 1 Receptor Market Size Estimates and Forecasts
1.4.1 Global Insulin Like Growth Factor 1 Receptor Revenue 2020-2031
1.4.2 Global Insulin Like Growth Factor 1 Receptor Sales 2020-2031
1.4.3 Global Insulin Like Growth Factor 1 Receptor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Like Growth Factor 1 Receptor Market Competition by Manufacturers
2.1 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Like Growth Factor 1 Receptor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Like Growth Factor 1 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Product Type & Application
2.7 Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Date of Enter into This Industry
2.8 Global Insulin Like Growth Factor 1 Receptor Market Competitive Situation and Trends
2.8.1 Global Insulin Like Growth Factor 1 Receptor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue
2.8.3 Global Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Like Growth Factor 1 Receptor Market Scenario by Region
3.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2020-2031
3.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2020-2025
3.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2026-2031
3.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2020-2031
3.3.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2020-2025
3.3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2026-2031
3.4 North America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
3.4.1 North America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2031)
3.4.3 North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
3.5.1 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2031)
3.5.3 Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
3.7.1 Latin America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2031)
3.7.3 Latin America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2020-2031)
4.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2020-2025)
4.1.2 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2026-2031)
4.1.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2020-2031)
4.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2020-2031)
4.2.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2020-2025)
4.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2026-2031)
4.2.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Like Growth Factor 1 Receptor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2020-2031)
5.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2020-2025)
5.1.2 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2026-2031)
5.1.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2020-2031)
5.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2020-2031)
5.2.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2020-2025)
5.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2026-2031)
5.2.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Like Growth Factor 1 Receptor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Company Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 AstraZeneca Plc
6.2.1 AstraZeneca Plc Company Information
6.2.2 AstraZeneca Plc Description and Business Overview
6.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
6.2.5 AstraZeneca Plc Recent Developments/Updates
6.3 Axelar AB
6.3.1 Axelar AB Company Information
6.3.2 Axelar AB Description and Business Overview
6.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
6.3.5 Axelar AB Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Company Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Company Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Company Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
6.6.5 Eli Lilly and Company Recent Developments/Updates
6.7 F. Hoffmann-La Roche Ltd.
6.7.1 F. Hoffmann-La Roche Ltd. Company Information
6.7.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.7.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.8 Genmab A/S
6.8.1 Genmab A/S Company Information
6.8.2 Genmab A/S Description and Business Overview
6.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
6.8.5 Genmab A/S Recent Developments/Updates
6.9 Immunomedics, Inc.
6.9.1 Immunomedics, Inc. Company Information
6.9.2 Immunomedics, Inc. Description and Business Overview
6.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.9.5 Immunomedics, Inc. Recent Developments/Updates
6.10 Insmed Incorporated
6.10.1 Insmed Incorporated Company Information
6.10.2 Insmed Incorporated Description and Business Overview
6.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
6.10.5 Insmed Incorporated Recent Developments/Updates
6.11 Merck & Co., Inc.
6.11.1 Merck & Co., Inc. Company Information
6.11.2 Merck & Co., Inc. Description and Business Overview
6.11.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.11.5 Merck & Co., Inc. Recent Developments/Updates
6.12 Merrimack Pharmaceuticals, Inc.
6.12.1 Merrimack Pharmaceuticals, Inc. Company Information
6.12.2 Merrimack Pharmaceuticals, Inc. Description and Business Overview
6.12.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.12.5 Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
6.13 Novartis AG
6.13.1 Novartis AG Company Information
6.13.2 Novartis AG Description and Business Overview
6.13.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
6.13.5 Novartis AG Recent Developments/Updates
6.14 PharmAbcine, Inc.
6.14.1 PharmAbcine, Inc. Company Information
6.14.2 PharmAbcine, Inc. Description and Business Overview
6.14.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.14.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.14.5 PharmAbcine, Inc. Recent Developments/Updates
6.15 ProteoThera, Inc.
6.15.1 ProteoThera, Inc. Company Information
6.15.2 ProteoThera, Inc. Description and Business Overview
6.15.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.15.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
6.15.5 ProteoThera, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Like Growth Factor 1 Receptor Industry Chain Analysis
7.2 Insulin Like Growth Factor 1 Receptor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Like Growth Factor 1 Receptor Production Mode & Process Analysis
7.4 Insulin Like Growth Factor 1 Receptor Sales and Marketing
7.4.1 Insulin Like Growth Factor 1 Receptor Sales Channels
7.4.2 Insulin Like Growth Factor 1 Receptor Distributors
7.5 Insulin Like Growth Factor 1 Receptor Customer Analysis
8 Insulin Like Growth Factor 1 Receptor Market Dynamics
8.1 Insulin Like Growth Factor 1 Receptor Industry Trends
8.2 Insulin Like Growth Factor 1 Receptor Market Drivers
8.3 Insulin Like Growth Factor 1 Receptor Market Challenges
8.4 Insulin Like Growth Factor 1 Receptor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Insulin Like Growth Factor 1 Receptor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Insulin Like Growth Factor 1 Receptor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Insulin Like Growth Factor 1 Receptor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Insulin Like Growth Factor 1 Receptor Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Insulin Like Growth Factor 1 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Product Type & Application
 Table 12. Global Key Manufacturers of Insulin Like Growth Factor 1 Receptor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Like Growth Factor 1 Receptor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Like Growth Factor 1 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2020-2025)
 Table 19. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2026-2031)
 Table 21. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2020-2025)
 Table 23. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2026-2031)
 Table 25. North America Insulin Like Growth Factor 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Insulin Like Growth Factor 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Insulin Like Growth Factor 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2020-2025)
 Table 53. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2026-2031)
 Table 54. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2020-2025)
 Table 57. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2026-2031)
 Table 58. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2020-2025)
 Table 63. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2026-2031)
 Table 64. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2020-2025)
 Table 67. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2026-2031)
 Table 68. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Application (2026-2031)
 Table 70. Astellas Pharma Inc. Company Information
 Table 71. Astellas Pharma Inc. Description and Business Overview
 Table 72. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 74. Astellas Pharma Inc. Recent Developments/Updates
 Table 75. AstraZeneca Plc Company Information
 Table 76. AstraZeneca Plc Description and Business Overview
 Table 77. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product
 Table 79. AstraZeneca Plc Recent Developments/Updates
 Table 80. Axelar AB Company Information
 Table 81. Axelar AB Description and Business Overview
 Table 82. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Axelar AB Insulin Like Growth Factor 1 Receptor Product
 Table 84. Axelar AB Recent Developments/Updates
 Table 85. Boehringer Ingelheim GmbH Company Information
 Table 86. Boehringer Ingelheim GmbH Description and Business Overview
 Table 87. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product
 Table 89. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 90. Bristol-Myers Squibb Company Company Information
 Table 91. Bristol-Myers Squibb Company Description and Business Overview
 Table 92. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product
 Table 94. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 95. Eli Lilly and Company Company Information
 Table 96. Eli Lilly and Company Description and Business Overview
 Table 97. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product
 Table 99. Eli Lilly and Company Recent Developments/Updates
 Table 100. F. Hoffmann-La Roche Ltd. Company Information
 Table 101. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 102. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product
 Table 104. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 105. Genmab A/S Company Information
 Table 106. Genmab A/S Description and Business Overview
 Table 107. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Genmab A/S Insulin Like Growth Factor 1 Receptor Product
 Table 109. Genmab A/S Recent Developments/Updates
 Table 110. Immunomedics, Inc. Company Information
 Table 111. Immunomedics, Inc. Description and Business Overview
 Table 112. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 114. Immunomedics, Inc. Recent Developments/Updates
 Table 115. Insmed Incorporated Company Information
 Table 116. Insmed Incorporated Description and Business Overview
 Table 117. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product
 Table 119. Insmed Incorporated Recent Developments/Updates
 Table 120. Merck & Co., Inc. Company Information
 Table 121. Merck & Co., Inc. Description and Business Overview
 Table 122. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 124. Merck & Co., Inc. Recent Developments/Updates
 Table 125. Merrimack Pharmaceuticals, Inc. Company Information
 Table 126. Merrimack Pharmaceuticals, Inc. Description and Business Overview
 Table 127. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 129. Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
 Table 130. Novartis AG Company Information
 Table 131. Novartis AG Description and Business Overview
 Table 132. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Novartis AG Insulin Like Growth Factor 1 Receptor Product
 Table 134. Novartis AG Recent Developments/Updates
 Table 135. PharmAbcine, Inc. Company Information
 Table 136. PharmAbcine, Inc. Description and Business Overview
 Table 137. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 139. PharmAbcine, Inc. Recent Developments/Updates
 Table 140. ProteoThera, Inc. Company Information
 Table 141. ProteoThera, Inc. Description and Business Overview
 Table 142. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product
 Table 144. ProteoThera, Inc. Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Insulin Like Growth Factor 1 Receptor Distributors List
 Table 148. Insulin Like Growth Factor 1 Receptor Customers List
 Table 149. Insulin Like Growth Factor 1 Receptor Market Trends
 Table 150. Insulin Like Growth Factor 1 Receptor Market Drivers
 Table 151. Insulin Like Growth Factor 1 Receptor Market Challenges
 Table 152. Insulin Like Growth Factor 1 Receptor Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Like Growth Factor 1 Receptor
 Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Insulin Like Growth Factor 1 Receptor Market Share by Type: 2024 & 2031
 Figure 4. BI-893923 Product Picture
 Figure 5. CT-707 Product Picture
 Figure 6. 1R-E1 Product Picture
 Figure 7. ATL-1101 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Insulin Like Growth Factor 1 Receptor Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Insulin Like Growth Factor 1 Receptor Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global Insulin Like Growth Factor 1 Receptor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Insulin Like Growth Factor 1 Receptor Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Insulin Like Growth Factor 1 Receptor Sales (2020-2031) & (K Pcs)
 Figure 17. Global Insulin Like Growth Factor 1 Receptor Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Insulin Like Growth Factor 1 Receptor Report Years Considered
 Figure 19. Insulin Like Growth Factor 1 Receptor Sales Share by Manufacturers in 2024
 Figure 20. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Insulin Like Growth Factor 1 Receptor Players: Market Share by Revenue in Insulin Like Growth Factor 1 Receptor in 2024
 Figure 22. Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Insulin Like Growth Factor 1 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 25. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 29. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2020-2031)
 Figure 37. China Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Insulin Like Growth Factor 1 Receptor by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Type (2020-2031)
 Figure 59. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Insulin Like Growth Factor 1 Receptor by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Application (2020-2031)
 Figure 62. Global Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Insulin Like Growth Factor 1 Receptor Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools